- Home
- PYXS vs DOMH Comparison
PYXS vs DOMH Comparison
Compare PYXS & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYXS
- DOMH
- Stock Information
- Founded
- PYXS 2018
- DOMH 1967
- Country
- PYXS United States
- DOMH United States
- Employees
- PYXS N/A
- DOMH N/A
- Industry
- PYXS Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- PYXS Health Care
- DOMH Health Care
- Exchange
- PYXS Nasdaq
- DOMH Nasdaq
- Market Cap
- PYXS 75.0M
- DOMH 83.3M
- IPO Year
- PYXS 2021
- DOMH N/A
- Fundamental
- Price
- PYXS $1.14
- DOMH $4.95
- Analyst Decision
- PYXS Strong Buy
- DOMH
- Analyst Count
- PYXS 5
- DOMH 0
- Target Price
- PYXS $9.00
- DOMH N/A
- AVG Volume (30 Days)
- PYXS 706.6K
- DOMH 276.9K
- Earning Date
- PYXS 08-13-2025
- DOMH 08-07-2025
- Dividend Yield
- PYXS N/A
- DOMH 6.41%
- EPS Growth
- PYXS N/A
- DOMH N/A
- EPS
- PYXS N/A
- DOMH N/A
- Revenue
- PYXS N/A
- DOMH $24,891,000.00
- Revenue This Year
- PYXS N/A
- DOMH N/A
- Revenue Next Year
- PYXS N/A
- DOMH N/A
- P/E Ratio
- PYXS N/A
- DOMH N/A
- Revenue Growth
- PYXS N/A
- DOMH 630.80
- 52 Week Low
- PYXS $0.83
- DOMH $0.83
- 52 Week High
- PYXS $5.39
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- PYXS 51.02
- DOMH 44.76
- Support Level
- PYXS $1.04
- DOMH $4.94
- Resistance Level
- PYXS $1.24
- DOMH $5.21
- Average True Range (ATR)
- PYXS 0.08
- DOMH 0.40
- MACD
- PYXS -0.00
- DOMH -0.08
- Stochastic Oscillator
- PYXS 53.57
- DOMH 0.64
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.